Leipzig
Universitätsklinikum Leipzig
The proteasome inhibitor marizomib shows antiproliferative effects in all three grades of meningioma
SAM-Score: A novel approach to predict tumor recurrence of sporadic cranial WHO grade 1 meningioma
The proteasome inhibitor marizomib shows antiproliferative effects in all three grades of meningioma